Literature DB >> 16922728

CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes.

A L Young1, R Kellermayer, R Szigeti, A Tészás, S Azmi, J T Celebi.   

Abstract

Brooke-Spiegler syndrome (BSS), familial cylindromatosis (FC), and multiple familial trichoepithelioma (MFT), originally described as distinct inherited disorders, are characterized by a variety of skin appendage neoplasms. Mutations in the CYLD gene are found in individuals with these syndromes. We describe a single family with affected members exhibiting either the FC or the MFT phenotypes associated with a mutation in the CYLD gene. These findings support the notion that BSS, FC, and MFT represent phenotypic variation of a single defect. Of interest, one of the affected individuals described in this report exhibits a severe phenotype illustrating the morbidity of the disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16922728     DOI: 10.1111/j.1399-0004.2006.00667.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  17 in total

Review 1.  The role of deubiquitinating enzymes in spermatogenesis.

Authors:  Bharathi Suresh; Junwon Lee; Seok-Ho Hong; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2015-09-08       Impact factor: 9.261

2.  The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.

Authors:  Atsushi Uematsu; Kohki Kido; Hirotaka Takahashi; Chikako Takahashi; Yuta Yanagihara; Noritaka Saeki; Shuhei Yoshida; Masashi Maekawa; Mamoru Honda; Tsutomu Kai; Kouhei Shimizu; Shigeki Higashiyama; Yuuki Imai; Fuminori Tokunaga; Tatsuya Sawasaki
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

3.  Cylindroma transforming into basal cell carcinoma in a patient with Brooke-Spiegler syndrome.

Authors:  Justyna Sicinska; Adriana Rakowska; Joanna Czuwara-Ladykowska; Andrzej Mroz; Marcin Lipinski; Anna Nasierowska-Guttmejer; Jolanta Sikorska; Katarzyna Sklinda; Monika Slowinska; Elzbieta Kowalska-Oledzka; Irena Walecka; Jerzy Walecki; Lidia Rudnicka
Journal:  J Dermatol Case Rep       Date:  2007-12-29

4.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

5.  [Hereditary head and neck tumors].

Authors:  S Schwarz-Furlan; C Brase; P Stockmann; I Furlan; A Hartmann
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 6.  Brooke-Spiegler Syndrome and Phenotypic Variants: An Update.

Authors:  Dmitry V Kazakov
Journal:  Head Neck Pathol       Date:  2016-03-14

7.  A large family with CYLD cutaneous syndrome: medical genetics at the community level.

Authors:  Anderson Pontes Arruda; Augusto César Cardoso-Dos-Santos; Luiza Monteavaro Mariath; Mariléa Furtado Feira; Thayne Woycinck Kowalski; Kalina Ribeiro Fontenele Bezerra; Leonardo Augusto Coelho Torres da Silva; Erlane Marques Ribeiro; Lavinia Schuler-Faccini
Journal:  J Community Genet       Date:  2019-12-03

Review 8.  Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.

Authors:  Patrick W Blake; Jorge R Toro
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

Review 9.  Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review.

Authors:  Isabelle Cleynen; Peter Jüni; Geertruida E Bekkering; Eveline Nüesch; Camila T Mendes; Stefanie Schmied; Stefan Wyder; Eliane Kellen; Peter M Villiger; Paul Rutgeerts; Séverine Vermeire; Daniel Lottaz
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.

Authors:  Neil Rajan; James A A Langtry; Alan Ashworth; Catherine Roberts; Pam Chapman; John Burn; Alison H Trainer
Journal:  Arch Dermatol       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.